{"id":"clm_D4ADC56D2F76","entity":"astrazeneca","predicate":"operating_income","value":"5,162,000,000 United States dollar","value_json":{"fy":2020,"accn":"0001104659-21-022456","form":"20-F","filed":"2021-02-16","concept":"ifrs-full:ProfitLossFromOperatingActivities"},"valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca operating income: 5,162,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_D4ADC56D2F76, https://asof.is/claim/clm_D4ADC56D2F76, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465921022456/0001104659-21-022456-index.htm.","url":"https://asof.is/claim/clm_D4ADC56D2F76","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_10DEC07C1593","supersedes":["clm_CA91157E8FEC"],"first_seen_at":"2026-11-08T15:36:59.840457+00:00","updated_at":"2026-11-08T15:36:59.840457+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465921022456/0001104659-21-022456-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2020, filed 2021-02-16"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}